DE543604C - Process for the permanent sterilization of healing serums - Google Patents

Process for the permanent sterilization of healing serums

Info

Publication number
DE543604C
DE543604C DE1930543604D DE543604DD DE543604C DE 543604 C DE543604 C DE 543604C DE 1930543604 D DE1930543604 D DE 1930543604D DE 543604D D DE543604D D DE 543604DD DE 543604 C DE543604 C DE 543604C
Authority
DE
Germany
Prior art keywords
healing
serums
magnesium
magnesium hydroxide
permanent sterilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1930543604D
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FRANTISEK HOCH
JAN BECKA DR
Original Assignee
FRANTISEK HOCH
JAN BECKA DR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FRANTISEK HOCH, JAN BECKA DR filed Critical FRANTISEK HOCH
Application granted granted Critical
Publication of DE543604C publication Critical patent/DE543604C/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

Verfahren zur Dauersterilisierung von Heilseren Der Vorgang der üblichen aktiven Immunisierung mit einem Toxin oder mit einer Bazillenemulsion bei Pferden ist sehr zeitraubend und kostspielig, weil eine Zeit von mindestens 3 Wochen erforderlich ist, um in dem immunisierten Tiere eine genügend hohe Konzentration von therapeutischen Stoffen zu erzeugen. Häufigere Blutentnahme für Serumerzeugung ruft bei den Tieren eine Schwäche hervor, ebenso schwächt die Toxinimpfung ebenfalls die Tiere. Derartige Seren müssen steril aufbewahrt und nach Öffnung des Gefäßes rasch verbraucht werden, was in der veterinären Praxis Schwierigkeiten und unnötige Kosten verursacht.Procedure for permanent sterilization of healing serums The process of the usual active immunization with a toxin or with a bacilli emulsion in horses is very time consuming and costly because it takes at least 3 weeks is to provide a sufficiently high concentration of therapeutic in the immunized animal To produce fabrics. More frequent blood sampling for serum production calls for the animals a weakness, just as the toxin vaccination also weakens the animals. Such Serums must be kept sterile and consumed quickly after opening the container. which causes difficulties and unnecessary costs in veterinary practice.

Die Erfindung beruht nun auf der Erkenntnis, daß durch in Magnesiumsalzlösungen suspendiertes, fein verteiltes bis kolloidales Magnesiumhydroxyd leicht zersetzliche organische Substanzen, insbesondere Eiweißstoffe der verschiedensten Art (auchLeimlösungen), für lange Zeit konserviert werden können, ohne daß die chemische Zusammensetzung und die spezifischen Eigenschaften der konservierten Produkte irgendwie verändert werden.The invention is based on the knowledge that by in magnesium salt solutions suspended, finely divided to colloidal magnesium hydroxide, easily decomposable organic substances, in particular proteins of various kinds (including glue solutions), can be preserved for a long time without affecting the chemical composition and somehow changed the specific properties of the preserved products will.

Eine besondere vorteilhafte Anwendung dieser Erkenntnis, die nicht für Magnesiumhydroxyd beliebiger Herkunft zutrifft, sondern nur für Suspensionen der vorgenannten Art, ist die Verwendung als Zusatz zu Heilseren. Wenn man Heilseren bekannter Art mit in Alkalisalz- oder Magnesiumsalzlösungen oder in Gemischen der beiden Lösungen suspendiertem, fein verteiltem bis kolloidalem Magnesiumhydroxyd versetzt, so werden die damit behandelten Heilseren dauernd sterilisiert. Eine solche dem Heilserum einverleibte Suspension wird bei subkutaner Injektion völlig resorbiert.A particularly beneficial application of this knowledge, which is not applies to magnesium hydroxide of any origin, but only to suspensions of the aforementioned type, is used as an additive to healing serums. If you have healing serums known type with in alkali salt or magnesium salt solutions or in mixtures of finely divided to colloidal magnesium hydroxide suspended in both solutions the healing serums treated with it are continuously sterilized. Such The suspension incorporated in the healing serum is completely absorbed by subcutaneous injection.

Solche dauernd steril bleibenden Heilseren lassen sich gemäß der Erfindung in vitro in der Weise herstellen, daß einem Heilserum bekannter Art in einem bestimmten Verhältnis Magnesiumhydroxyd und verschiedene Salze beigemengt werden, so daß eine homogene Suspension entsteht. Diese Mischung besitzt eine Wirkung, als wenn sie ein Heilserum mit einem hohen Titer wäre, und verdirbt nicht, auch wenn sie nicht steril aufbewahrt wird. Beispiel 15 g kolloidales Magnesiumhydroxy d, 8 g Natriumchlorid, 0,3 g Magnesiumchlorid werden mit 877 g Wasser so zerrieben, daß eine feine Emulsion entsteht. Dann werden ioo g eines Heilserums bekannter Art zugesetzt. Vor der Injektion wird die Mischung durchgeschüttelt. Beim Einspritzen dieser Mischung stellten sich keine Symptome von Serumkrankheit ein.Such healing serums which remain sterile can be produced according to the invention Manufacture in vitro in such a way that a healing serum of a known type in a certain Ratio of magnesium hydroxide and various salts are added, so that a homogeneous suspension is formed. This mixture has an effect as if it were would be a healing serum with a high titer, and does not spoil, even if it does not is kept sterile. Example 15 g colloidal magnesium hydroxide, 8 g sodium chloride, 0.3 g of magnesium chloride are triturated with 877 g of water so that a fine emulsion arises. Then 100 g of a known type of healing serum are added. before the mixture is shaken thoroughly after the injection. When injecting this mixture there were no symptoms of serum sickness.

Das Verfahren dient besonders zur Sterilisierung von Rotlaufserum, es ist aber auch, wie bemerkt, für alle bekannten Heilseren anwendbar.The process is particularly useful for the sterilization of red runner serum, but, as noted, it can also be used for all known healing serums.

Claims (1)

PATENT ANSPIZÜCIIE: i. Verfahren zur Dauersterilisierung von Heilseren gegen Infektionskrankheiten, wie z. B. Diphterie, Schweinerotlauf u. dgl., dadurch gekennzeichnet, daß Heilseren bekannter Art mit einem in Alkalisalz- oder Magnesiumsalzlösungen oder in Gemischen der beiden Lösungen suspendierten, fein verteilten bis kolloidalen Magnesiumhydroxyd versetzt werden. a. Verfahren nach Anspruch i, dadurch gekennzeichnet, daß die Suspension des Magnesiumhydroxyds in einer wässerigen Lösung von Natriumchlorid und Magnesiumchlorid erfolgt.PATENT INSPECTION: i. Process for the permanent sterilization of healing serums against infectious diseases such as B. diphtheria, swine rot and the like., As a result characterized that healing sera of known type with one in alkali salt or magnesium salt solutions or finely divided to colloidal suspended in mixtures of the two solutions Magnesium hydroxide are added. a. Method according to claim i, characterized in that that the suspension of magnesium hydroxide in an aqueous solution of sodium chloride and magnesium chloride takes place.
DE1930543604D 1929-11-22 1930-01-19 Process for the permanent sterilization of healing serums Expired DE543604C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS543604X 1929-11-22

Publications (1)

Publication Number Publication Date
DE543604C true DE543604C (en) 1932-02-08

Family

ID=5453506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1930543604D Expired DE543604C (en) 1929-11-22 1930-01-19 Process for the permanent sterilization of healing serums

Country Status (1)

Country Link
DE (1) DE543604C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2454755A (en) * 1945-02-07 1948-11-23 American Cyanamid Co Production of toxins and toxoids
US2473255A (en) * 1946-01-15 1949-06-14 American Cyanamid Co Process of preparing modified protein

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2454755A (en) * 1945-02-07 1948-11-23 American Cyanamid Co Production of toxins and toxoids
US2473255A (en) * 1946-01-15 1949-06-14 American Cyanamid Co Process of preparing modified protein

Similar Documents

Publication Publication Date Title
DE2500076A1 (en) PROCEDURE FOR INCREASING THE INTRAVENOUS COMPATIBILITY OF GAMMA GLOBULINS EXEMPLED FROM BLOOD OR BLOOD PRODUCTS
DE2602997C2 (en) Lyophilized collagen preparation and process for their manufacture
DE543604C (en) Process for the permanent sterilization of healing serums
DE1053736B (en) Process to increase the solubility of therapeutically active substances in water
DE1227615B (en) Process for the production of stable vaccine preparations
DE1517751C3 (en) Method for preventing the formation of flaky lysozyme and / or lysozyme salt precipitates in aqueous solutions containing lysozyme and / or lysozyme salts
AT222274B (en)
DE946061C (en) Process for the enzymatic hydrolysis of proteins and autolysis of animal tissues
DE353493C (en) Process for the production of a non-dusting and non-corrosive fertilizer
DE574587C (en) Process for obtaining vaccines suitable for immunization against infections by infectious agents
DE725294C (en) Process for the manufacture of a vaccine to prevent and cure canine distemper
DE642980C (en) Process for the production of therapeutically effective solutions from bacteria
DE879591C (en) Process to increase the shelf life of thrombin in aqueous solution
DE430446C (en) Process for the production of a healing and protective serum effective against canine distemper
DE462187C (en) Process for the preparation of a durable, sterilizable, therapeutically valuable complex gold sodium thiosulfate solution
EP0524971B1 (en) Decontaminated biological material
DE1904001C (en) Process for the production of a vac cine against meningitis cerebrospinalis
DE535676C (en) Process for the manufacture of anti-bacterial agents
DE173789C (en)
DE375108C (en) Process for the preparation of a vaccine from live, native or acid-fast bacilli pretreated with immune serum
DE1229677B (en) Process for the preparation of injectable emulsions containing antigens
DE1177287B (en) Process for the manufacture of vaccines against poliomyelitis
DE443588C (en) Process for producing durable polyvalent and polygenic vaccines
DE503053C (en) Process for the aftertreatment of catgut
DE637792C (en) Process for the production of durable solutions of complex lead salts